We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
151
Kymera Therapeutics
KYMR
$9.05B
$23.2M 0.16%
394,991
-16,000
-4% -$928K
ENPH icon
152
Enphase Energy
ENPH
$5.01B
$23.2M 0.16%
154,511
+2,581
+2% +$443K
HASI icon
153
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$22.9M 0.16%
427,769
+10,298
+2% +$587K
WST icon
154
West Pharmaceutical
WST
$23.3B
$22.9M 0.16%
53,868
-14,891
-22% -$6.28M
BMY icon
155
Bristol-Myers Squibb
BMY
$128B
$22.5M 0.15%
380,950
-18,433
-5% -$1.21M
XOM icon
156
ExxonMobil
XOM
$642B
$22.3M 0.15%
379,626
+8,529
+2% +$486K
CMG icon
157
Chipotle Mexican Grill
CMG
$42.6B
$22.2M 0.15%
611,500
-315,400
-34% -$11.5M
NFLX icon
158
Netflix
NFLX
$293B
$22.1M 0.15%
361,620
-71,840
-17% -$3.95M
EXAS
159
DELISTED
Exact Sciences
EXAS
$22M 0.15%
230,859
-8,133
-3% -$859K
CRNC icon
160
Cerence
CRNC
$375M
$21.9M 0.15%
227,528
+46,928
+26% +$5.12M
MKC icon
161
McCormick & Company Non-Voting
MKC
$13.6B
$21.8M 0.15%
269,301
+138,296
+106% +$11.9M
AMRC icon
162
Ameresco
AMRC
$1.12B
$21.8M 0.15%
372,639
+5,133
+1% +$338K
HLT icon
163
Hilton Worldwide
HLT
$75.3B
$21.4M 0.15%
155,382
-1,006
-0.6% -$127K
AFL icon
164
Aflac
AFL
$64.4B
$21.4M 0.15%
409,739
+350,534
+592% +$19.2M
BMRN icon
165
BioMarin Pharmaceuticals
BMRN
$11.6B
$21.3M 0.15%
276,207
+168,364
+156% +$13.3M
BBIO icon
166
BridgeBio Pharma
BBIO
$16.5B
$21.3M 0.15%
455,285
– –
LULU icon
167
lululemon athletica
LULU
$13.4B
$21.3M 0.15%
52,693
+2,380
+5% +$953K
ELV icon
168
Elevance Health
ELV
$82.1B
$21M 0.14%
56,350
-501
-0.9% -$190K
IOVA icon
169
Iovance Biotherapeutics
IOVA
$2.19B
$20.9M 0.14%
848,652
-171,774
-17% -$4.05M
ALLY icon
170
Ally Financial
ALLY
$13.3B
$20.9M 0.14%
380,571
+47,284
+14% +$2.45M
XNCR icon
171
Xencor
XNCR
$1.47B
$20.8M 0.14%
637,800
+133,256
+26% +$4.38M
SHOP icon
172
Shopify
SHOP
$165B
$20.8M 0.14%
153,120
+133,090
+664% +$19.9M
Y
173
DELISTED
Alleghany Corp
Y
$20.4M 0.14%
32,698
+7,616
+30% +$5.03M
TREX icon
174
Trex
TREX
$4.57B
$20.3M 0.14%
198,732
+28,825
+17% +$3.01M
TRIL
175
DELISTED
Trillium Therapeutics Inc.
TRIL
$20.2M 0.14%
1,150,280
+360,182
+46% +$4.21M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.